November 14, 2014 — According to a survey by KLAS, an independent research firm, Elekta's Mosaiq Oncology Information System earned the No. 1 ranking in the medical and/or radiology oncology category of KLAS' "Oncology 2014: Integration is Key" report. The survey of 247 customers of various vendors said that "Elekta has improved their Mosaiq interfaces to take a commanding lead over their competitors." Mosaiq scored 82.4 out of 100, 93 percent of customers said they would buy again and 96 percent confirmed that Mosaiq is part of their long-term plans.
This is the second year that it has received this recognition. It was also ranked highest in the KLAS' "Oncology 2013: Eyes Wide Open" report.
This year, the report indicated that in the "interface race," in which integration is more critical than functionality in the eyes of customers, providers were more pleased with Elekta's Mosaiq pharmacy interfaces than they were in the 2013 KLAS oncology report, achieving a rating of 8.0, eclipsing last year's mark of 7.1. "Elekta's single database for radiation and medical oncology continues to be a strength for the continuity of oncology care," the report states.
The survey also revealed high customer appreciation for the improved workflow automation that Elekta provides in Mosaiq via IQ Scripts, which "has been immensely helpful in speeding up workflow."
In the report, Mosaiq was the highest performer in five out of eight categories, covering both medical and radiation oncology.
Mosaiq is a complete patient information management system that efficiently manages patient care on a single solution, allowing effective treatment evaluation before, during and after delivery to ensure accuracy and safety. With more than 25 years of open systems support, Mosaiq connects seamlessly to virtually any linear accelerator and planning system from any vendor, giving centers the flexibility to choose solutions that perform optimally for their practice and patients.
For more information: www.elekta.com